Replies to post #2197 on Antares Pharma, Inc. (ATRS)

[rph_investor]

Jab, all I'm saying is that I don't think Antares would put QS M on the pipeline chart if it was scopolamine. They didn't have the rights to it a few months ago when they added it to the pipeline, and they still don't.